Epidermal Growth Factor Receptor (EGFR) and Vascular Endothelial Growth Factor (VEGF) expression in Sinonasal Inverted Papillomas

Mario Bilic*, Ena Klaric, Lana Kovac-Bilic, Selma Hodzic-Redzic and Sven Seiwerth

The aim of this study was to evaluate the expression of Epidermal Growth Factor Receptor (EGFR) and Vascular Endothelial Growth Factor (VEGF) in patients with primary inverted papilloma (IP), recurrence of IP and carcinoma based on IP.

The study was performed on an archived material of the 52 patients that were surgically treated because of the primary IP, recurrent IP and carcinoma that developed on the ground of IP on the Tertiary care University Center in the period of 18 years. The expression of the EGFR and VEGF were measured by an immunohistochemistry method using commercially available antibodies.

There is a significant difference in expression of EGFR comparing primary IP to recurrence and squamous cell carcinoma (SCC) in the region of squamous and dysplastic epithelium, and also in the region of metaplastic epithelium between primary IP and carcinoma. There is a significant difference in expression of VEGF compared primary IP to recurrence and SCC in the region of the squamous and dysplastic epithelium.

The recurrence of IP presents step in tumour’s transformation between benign lesion and carcinoma.

Keywords: Papilloma; Inverted; Receptor; Epidermal Growth Factor Receptor (EGFR); Vascular Endothelial Growth Factor (VEGF); Head and neck neoplasms

Published on: Dec 31, 2018 Pages: 101-106

Full Text PDF Full Text HTML DOI: 10.17352/2455-1759.000086
CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat